Jiaying Zhou

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma

Hao Sun, Si‐Yang Maggie Liu, Jiaying Zhou et al. · EBioMedicine · 2020 · 245 citations · Full text

Ru(II)-modified TiO2 nanoparticles for hypoxia-adaptive photo-immunotherapy of oral squamous cell carcinoma

Jiaying Zhou, Wenjin Wang, Chenyu Zhang et al. · Biomaterials · 2022 · 94 citations · Full text

Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients

Si‐Yang Maggie Liu, Hao Sun, Jiaying Zhou et al. · Biomarker Research · 2020 · 71 citations · Full text

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors

Lun-Xi Peng, Guang‐Ling Jie, Anna Li et al. · Experimental Hematology and Oncology · 2021 · 53 citations · Full text

Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells

Jiaying Zhou, Yabin Cheng, Liren Tang et al. · Oncotarget · 2016 · 52 citations · Full text